Import from '@/components/mdx'

Can I Take Vitamin B12 with Vyvanse? A Women's Guide to Safety, Interactions, and Dosing

The Short Answer: No Direct Interaction Exists

Vitamin B12 and Vyvanse do not interact directly. No pharmacokinetic data shows lisdexamfetamine altering B12 absorption, distribution, metabolism, or excretion. No pharmacodynamic data shows B12 blunting or amplifying Vyvanse's stimulant effect on dopamine and norepinephrine reuptake.

"no direct interaction" is not the same as "nothing to think about." Women taking Vyvanse often carry a cluster of comorbidities, including PCOS, binge eating disorder, depression, and insulin resistance, that independently affect B12 status. Working through those layers is where the real clinical value lies.

How Vyvanse Works in the Body

Vyvanse is a prodrug. After you swallow the capsule, intestinal and red-blood-cell enzymes cleave the lysine amino acid from the lisdexamfetamine molecule, releasing d-amphetamine. That conversion happens in the gut wall and blood, not in the liver's cytochrome P450 system. Because CYP enzymes are largely uninvolved, Vyvanse has fewer drug-nutrient interactions than many other medications that compete for the same metabolic enzymes.

D-amphetamine then increases synaptic dopamine and norepinephrine by reversing the direction of their transporters. B12 is a cofactor in one-carbon metabolism and myelin synthesis, not in catecholamine transporter function. The two systems simply do not overlap at a mechanistic level.

How Vitamin B12 is Absorbed

B12 absorption is intrinsic-factor dependent. Your stomach's parietal cells secrete intrinsic factor, which binds B12 from food and carries it to receptors in the terminal ileum. Amphetamines do not suppress parietal cell function and do not alter ileal transport receptors. High-dose supplemental B12 (cyanocobalamin or methylcobalamin at doses above 1,000 mcg) is also absorbed passively in small amounts independent of intrinsic factor, making supplementation effective even when the intrinsic-factor pathway is impaired.

Why Women on Vyvanse Are at Higher-Than-Average B12 Depletion Risk

This is where the clinical picture gets more specific, and where most generic "interaction checker" sites miss the point entirely.

The Metformin Connection

PCOS affects an estimated 8 to 13% of reproductive-age women, and metformin is one of the most commonly prescribed medications for it. ADHD and PCOS co-occur more often than chance: insulin resistance may share neurobiological pathways with executive dysfunction, though direct mechanistic studies in women are limited.

Metformin is a well-documented B12 depleter. A randomized controlled trial published in the BMJ, the HOME trial, showed that metformin users had significantly lower B12 concentrations than placebo after 4.3 years. Across observational studies, up to 30% of long-term metformin users develop biochemically low B12. The mechanism is reduced ileal calcium-dependent B12 absorption caused by metformin.

If you are taking Vyvanse for ADHD or binge eating disorder and also taking metformin for PCOS or insulin resistance, you face two compounding risks:

1. Metformin actively blocks B12 absorption.
2. Vyvanse suppresses appetite, reducing your dietary intake of B12-rich foods (meat, fish, eggs, dairy).

Neither mechanism involves a direct Vyvanse-B12 pharmacokinetic interaction. But the clinical outcome, a woman becoming B12-deficient, is the same.

Appetite Suppression and Dietary Depletion

Vyvanse is FDA-approved for moderate-to-severe binge eating disorder (BED) at doses of 50 mg or 70 mg per day. Appetite suppression is an expected effect. Women who under-eat on Vyvanse often reduce their consumption of animal proteins, the primary dietary source of B12. Strict vegetarian or vegan eating patterns, already common in women with BED during restriction cycles, compound this further. B12 is found in meaningful quantities almost exclusively in animal-derived foods; plant sources other than fortified products provide negligible amounts.

Hormonal Contraceptives and B12

A frequently overlooked data point: combined oral contraceptives may lower serum B12 by up to 20% through altered binding protein levels. Many women taking Vyvanse for ADHD are also on the pill for contraception or hormonal management. This does not cause frank deficiency on its own, but it adds to the cumulative depletion burden alongside metformin and dietary reduction.

Perimenopause and Post-Menopause: Gastric Acid Declines

Atrophic gastritis becomes more common after age 50, impairing the parietal cell function that produces intrinsic factor. Women in perimenopause or post-menopause who are prescribed Vyvanse (ADHD is frequently diagnosed or re-diagnosed in this life stage, when estrogen withdrawal unmasks executive dysfunction) should be screened for B12 deficiency as a baseline, not as an afterthought.

The WomanRx B12 Depletion Risk Framework for Women on Vyvanse

| Risk Factor | Adds to Depletion? | Action | |---|---|---| | Metformin co-use (PCOS, T2DM) | Yes, strongly | Annual serum B12 + MMA; supplement 500-1,000 mcg daily | | Oral contraceptive co-use | Modest | Check B12 if symptomatic | | Vegan or restrictive eating pattern | Yes | Supplement; monitor MMA | | Perimenopause or post-menopause | Yes (atrophic gastritis risk) | Baseline B12 screen | | None of the above | Minimal | No routine supplementation required |

Is There Any Pharmacodynamic Interaction Between B12 and Vyvanse?

Some online forums suggest B12 "boosts" or "blocks" Vyvanse. Neither claim is supported by clinical trial data.

The theoretical basis sometimes offered is that B12, as a methyl donor in one-carbon metabolism, might affect methylation of catecholamine pathways. This is speculative. No randomized controlled trial or well-designed observational study has measured lisdexamfetamine plasma concentrations or clinical ADHD outcomes as a function of B12 status. The Natural Medicines database rates the Vyvanse-B12 interaction as having no known interaction.

B12 does not affect urinary pH in a clinically meaningful way. Urinary pH matters for amphetamine excretion because alkaline urine increases reabsorption and extends amphetamine half-life while acidic urine speeds elimination. Vitamin C (ascorbic acid) is the supplement most clinically relevant to this mechanism. B12 does not share this chemistry.

Pregnancy and Lactation Safety

This section is required reading if you are pregnant, planning pregnancy, or breastfeeding.

Vyvanse in Pregnancy

Vyvanse carries an FDA Pregnancy Category C designation based on animal data showing fetal harm at high doses. Human data are limited and mostly retrospective. Amphetamine exposure in the first trimester has been associated with small-for-gestational-age outcomes and preterm birth in some cohort studies, though confounding by indication is difficult to eliminate.

ACOG advises that stimulant medications should be used in pregnancy only when the benefit clearly outweighs the risk, and that a shared decision-making conversation with your prescriber is required before and during pregnancy.

Vyvanse is not routinely recommended during pregnancy. If you are planning to conceive, discuss a taper or switch to non-stimulant options with your prescriber before stopping contraception.

B12 in Pregnancy

B12 is essential for fetal neural tube closure and neurological development. The recommended dietary allowance for B12 rises to 2.6 mcg per day during pregnancy and 2.8 mcg per day during lactation, up from 2.4 mcg in non-pregnant adults. Most prenatal vitamins contain adequate B12. If you have been on metformin, a restrictive diet, or oral contraceptives prior to conception, check your B12 level early in pregnancy.

Vyvanse During Breastfeeding

Amphetamines are excreted into breast milk. The American Academy of Pediatrics lists amphetamines as drugs of concern during breastfeeding, citing potential effects on infant sleep, feeding, and cardiovascular function. Most expert guidance recommends avoiding Vyvanse while breastfeeding. If ADHD treatment is necessary postpartum, discuss alternatives with your prescriber.

B12 supplementation during breastfeeding is safe and recommended if dietary intake is inadequate, particularly for women following vegan or vegetarian diets.

Contraception Requirement

Because Vyvanse carries fetal risk and requires stable psychiatric management, reliable contraception is strongly advised while taking it if you do not wish to become pregnant. This is especially relevant because ADHD in women is associated with lower rates of consistent contraceptive use.

Who This Is Right For and Not Right For

Women Who Can Take B12 With Vyvanse Without Concern

• Reproductive-age women on Vyvanse alone, eating a varied omnivore diet, with no metformin or OCP co-use
• Women with confirmed B12 deficiency regardless of Vyvanse status (B12 repletion is indicated on its own merits)
• Perimenopause and post-menopause women taking Vyvanse who screen low for B12

Women Who Need Closer Monitoring

• Women on metformin for PCOS or diabetes alongside Vyvanse: annual serum B12 and methylmalonic acid
• Women on Vyvanse with restrictive eating patterns or vegan diets: supplementation and monitoring are reasonable
• Women over 50 on Vyvanse: baseline B12 with atrophic gastritis risk in mind

Women Who Should Not Start or Continue Vyvanse Without Specific Guidance

• Pregnant women: Vyvanse is not routinely recommended; discuss with your prescriber before conception
• Breastfeeding women: avoid Vyvanse; B12 supplementation is safe and often needed
• Women with prior history of cardiac arrhythmia or uncontrolled hypertension: these are independent contraindications to stimulants and not related to B12

How to Supplement B12 If You Need It While on Vyvanse

Forms of B12

The two most widely used supplemental forms are cyanocobalamin and methylcobalamin. At doses above 1,000 mcg, both are absorbed passively and bypass the intrinsic-factor pathway. A Cochrane review found no clinically meaningful difference in efficacy between oral cyanocobalamin and intramuscular B12 for mild-to-moderate deficiency, though severe or absorption-related deficiency may still warrant injections.

For women on metformin with documented low B12, oral supplementation at 1,000 mcg per day reduced deficiency rates in observational data. Your prescriber or dietitian should guide the specific dose and form based on your serum B12 and MMA levels.

Timing With Vyvanse

No required separation window exists. Vyvanse is best taken in the morning. B12 can be taken at any time of day. Combining them in a morning routine is fine.

Lab Tests That Matter

• Serum B12: screens for deficiency; values below 200 pg/mL are typically considered deficient, though some labs use 300 pg/mL as a clinical threshold
• Methylmalonic acid (MMA): rises before serum B12 falls; a more sensitive marker of functional deficiency. MMA above 0.4 micromol/L suggests tissue-level B12 insufficiency even when serum B12 appears normal
• Homocysteine: elevated when B12, folate, or B6 is low; an additional marker used when neuropathy is a concern

ADHD, Women, and the B12-Mood-Energy Overlap

Women with ADHD are diagnosed at lower rates than men and often later in life, partly because symptom presentation skews toward inattention and emotional dysregulation rather than hyperactivity. A 2020 systematic review in the Journal of Psychiatry & Neuroscience found that women with ADHD experience higher rates of anxiety, depression, and low self-esteem than men with ADHD, creating a diagnostic delay that averages several years.

B12 deficiency symptoms, specifically fatigue, brain fog, low mood, and poor concentration, overlap almost completely with ADHD inattentive symptoms and with perimenopausal cognitive complaints. A woman who starts Vyvanse and notices inadequate symptom response might, in some cases, have an undetected B12 deficiency compounding her picture. Checking B12 before attributing a poor Vyvanse response solely to dose inadequacy is a practical clinical step that costs little.

[Dr. Maya Okafor, MD, WomanRx Medical Reviewer:] "In my practice I see women whose apparent stimulant underresponse resolves partially after B12 repletion. It's not that B12 treats ADHD. It's that you can't optimize attention with untreated nutritional deficiency in the background. These are separate problems that need separate fixes."

What the Evidence Gap Looks Like

The clinical data on lisdexamfetamine specifically in women is thinner than it should be. The key BED trials for Vyvanse, SPD489-343 and SPD489-344, enrolled predominantly female participants because BED affects women at higher rates, which is useful. But the ADHD trial program enrolled more men than women, and sex-stratified pharmacokinetic analyses for lisdexamfetamine in women across hormonal states (follicular vs luteal phase, OCP use, pregnancy) are not in the public domain.

No published trial has directly examined B12 status as a predictor or modifier of lisdexamfetamine response. The guidance in this article draws on the mechanistic evidence that B12 and amphetamine metabolism do not overlap, combined with the well-documented indirect depletion pathways through metformin and diet. Women should know that distinction.

A Practical Checklist Before You Start Both

1. Tell your prescriber all supplements and medications, including metformin and oral contraceptives.
2. If you are on metformin, ask for a baseline serum B12 and MMA.
3. If you are vegan or have significantly reduced your food intake on Vyvanse, discuss B12 supplementation with your prescriber or registered dietitian.
4. If you are trying to conceive, have a dedicated conversation about Vyvanse before stopping contraception.
5. If you are perimenopausal and newly diagnosed with ADHD, request a B12 screen alongside other labs.
6. If your Vyvanse response feels flat despite adequate dosing, rule out B12 deficiency, thyroid dysfunction, iron deficiency anemia, and sleep disorders before escalating the dose.